Jonathan Violin, Chief Executive Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 100,000 shares at $36.80 ($3.7M) on 2023-02-02, disclosed to the SEC on 2023-02-07.
Open-market sale of $3.7M VRDN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.80 | 50,000 | $1.8M | 50.0% |
| 2 | $36.80 | 50,000 | $1.8M | 50.0% |
| Total | $36.80 avg | 100,000 | $3.7M | 100% |
| Filing → |
| VRDN | SELL | 2022-04-05 | $1.1M | — | Filing → |
| VRDN | SELL | 2022-03-03 | $1.1M | — | Filing → |
| VRDN | SELL | 2022-02-03 | $1.1M | — | Filing → |